Dr. David A. Schwartz, MD
Cardiology (Cardiovascular Disease Physician)
At a glance
- In the NPI registry since
- 2005
Licensed in Texas since 1976, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
TX license E6613 (first issued 1976; canc non-renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 986 | 606 |
| Anticoagulant management of patient taking warfarin | 852 | 304 |
| Established patient office or other outpatient visit, 30-39 minutes | 764 | 501 |
| Insertion of needle into vein for collection of blood sample | 737 | 458 |
| Established patient office or other outpatient visit, 20-29 minutes | 423 | 320 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 384 | 321 |
| Blood test, clotting time | 238 | 105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 55 | 21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 52 | 20 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | 39 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in Plano, TX | 400 |
| Atorvastatin Calcium Other prescribers in Plano, TX | 247 |
| Metoprolol Succinate Other prescribers in Plano, TX | 232 |
| Eliquis (apixaban) Other prescribers in Plano, TX | 172 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Plano, TX | 149 |
| Amlodipine Besylate Other prescribers in Plano, TX | 114 |
| Carvedilol Other prescribers in Plano, TX | 95 |
| Losartan Potassium Other prescribers in Plano, TX | 76 |
| Repatha Sureclick (evolocumab) Other prescribers in Plano, TX | 74 |
| Xarelto (rivaroxaban) Other prescribers in Plano, TX | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,746 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
E.r. Squibb & Sons, L.l.c.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.